BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hunt A, Hansen V, Oelfke U, Nill S, Hafeez S. Adaptive Radiotherapy Enabled by MRI Guidance. Clinical Oncology 2018;30:711-9. [DOI: 10.1016/j.clon.2018.08.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Kroll C, Dietrich O, Bortfeldt J, Kamp F, Neppl S, Belka C, Parodi K, Baroni G, Paganelli C, Riboldi M. Integration of spatial distortion effects in a 4D computational phantom for simulation studies in extra-cranial MRI-guided radiation therapy: Initial results. Med Phys 2021;48:1646-60. [PMID: 33220073 DOI: 10.1002/mp.14611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Schernberg A, Kumar T, Achkar S, Espenel S, Bockel S, Majer M, Escande A, Mignot F, Annede P, Monnier L, Huguet F, Chargari C. Incorporating Magnetic Resonance Imaging (MRI) Based Radiation Therapy Response Prediction into Clinical Practice for Locally Advanced Cervical Cancer Patients. Seminars in Radiation Oncology 2020;30:291-9. [DOI: 10.1016/j.semradonc.2020.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Otazo R, Lambin P, Pignol JP, Ladd ME, Schlemmer HP, Baumann M, Hricak H. MRI-guided Radiation Therapy: An Emerging Paradigm in Adaptive Radiation Oncology. Radiology 2021;298:248-60. [PMID: 33350894 DOI: 10.1148/radiol.2020202747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Esposito M, Villaggi E, Bresciani S, Cilla S, Falco MD, Garibaldi C, Russo S, Talamonti C, Stasi M, Mancosu P. Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods. Radiother Oncol 2020;149:158-67. [PMID: 32416282 DOI: 10.1016/j.radonc.2020.05.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
5 Lim Joon D, Smith D, Tacey M, Schneider M, Harris B, Ong WL, Foroudi F, Jenkins T, Wada M, Chao M, Rykers K, Khoo V. A phantom study to contrast and compare polymer and gold fiducial markers in radiotherapy simulation imaging. Sci Rep 2021;11:8931. [PMID: 33903651 DOI: 10.1038/s41598-021-88300-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lee MH, Kim KH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI. Volumetric changes of intracranial metastases during the course of fractionated stereotactic radiosurgery and significance of adaptive planning. J Neurosurg 2019;:1-6. [PMID: 31151111 DOI: 10.3171/2019.3.JNS183130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Shortall J, Vasquez Osorio E, Cree A, Song Y, Dubec M, Chuter R, Price G, McWilliam A, Kirkby K, Mackay R, van Herk M. Inter- and intra-fractional stability of rectal gas in pelvic cancer patients during MRIgRT. Med Phys 2021;48:414-26. [PMID: 33164217 DOI: 10.1002/mp.14586] [Reference Citation Analysis]
8 Blake SW, Stapleton A, Brown A, Curtis S, Ash-Miles J, Dennis E, Masson S, Bowers D, Hilman S. A study of the clinical, treatment planning and dosimetric feasibility of dose painting in external beam radiotherapy of prostate cancer. Phys Imaging Radiat Oncol 2020;15:66-71. [PMID: 33458328 DOI: 10.1016/j.phro.2020.07.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shortall J, Vasquez Osorio E, Chuter R, Green A, Mcwilliam A, Kirkby K, Mackay R, Herk M. Characterizing local dose perturbations due to gas cavities in magnetic resonance‐guided radiotherapy. Med Phys 2020;47:2484-94. [DOI: 10.1002/mp.14120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Cellini F, Tagliaferri L, Frascino V, Alitto AR, Fionda B, Boldrini L, Romano A, Casà C, Catucci F, Mattiucci GC, Valentini V. Radiation therapy for prostate cancer: What's the best in 2021. Urologia 2021;:3915603211042335. [PMID: 34496707 DOI: 10.1177/03915603211042335] [Reference Citation Analysis]
11 Kroll C, Dietrich O, Bortfeldt J, Paganelli C, Baroni G, Kamp F, Neppl S, Belka C, Parodi K, Opel M, Riboldi M. Improving the modelling of susceptibility-induced spatial distortions in MRI-guided extra-cranial radiotherapy. Phys Med Biol 2019;64:205006. [DOI: 10.1088/1361-6560/ab447c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Moteabbed M, Smeets J, Hong TS, Janssens G, Labarbe R, Wolfgang JA, Bortfeld TR. Toward MR-integrated proton therapy: modeling the potential benefits for liver tumors. Phys Med Biol 2021;66. [PMID: 34407528 DOI: 10.1088/1361-6560/ac1ef2] [Reference Citation Analysis]
13 Mitchell A, Ingle M, Smith G, Chick J, Diamantopoulos S, Goodwin E, Herbert T, Huddart R, Mcnair H, Oelfke U, Nill S, Dunlop A, Hafeez S. Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac. Clinical and Translational Radiation Oncology 2022. [DOI: 10.1016/j.ctro.2022.04.008] [Reference Citation Analysis]
14 Ingle M, Lalondrelle S. Current Status of Anatomical Magnetic Resonance Imaging in Brachytherapy and External Beam Radiotherapy Planning and Delivery. Clin Oncol (R Coll Radiol) 2020;32:817-27. [PMID: 33169690 DOI: 10.1016/j.clon.2020.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li M, Zhang Q, Yang K. Role of MRI-Based Functional Imaging in Improving the Therapeutic Index of Radiotherapy in Cancer Treatment. Front Oncol 2021;11:645177. [PMID: 34513659 DOI: 10.3389/fonc.2021.645177] [Reference Citation Analysis]
16 Glide-Hurst CK, Lee P, Yock AD, Olsen JR, Cao M, Siddiqui F, Parker W, Doemer A, Rong Y, Kishan AU, Benedict SH, Li XA, Erickson BA, Sohn JW, Xiao Y, Wuthrick E. Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology. Int J Radiat Oncol Biol Phys 2021;109:1054-75. [PMID: 33470210 DOI: 10.1016/j.ijrobp.2020.10.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
17 Kong V, Hansen VN, Hafeez S. Image-guided Adaptive Radiotherapy for Bladder Cancer. Clin Oncol (R Coll Radiol) 2021;33:350-68. [PMID: 33972024 DOI: 10.1016/j.clon.2021.03.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Badey A, Barateau A, Delaby N, Fau P, Garcia R, De Crevoisier R, Lisbona A. État des lieux de la radiothérapie adaptative en 2019 : de la mise en place à l’utilisation clinique. Cancer/Radiothérapie 2019;23:581-91. [DOI: 10.1016/j.canrad.2019.07.142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Mejnertsen L, Hewson E, Nguyen DT, Booth J, Keall P. Dose-based optimisation for multi-leaf collimator tracking during radiation therapy. Phys Med Biol 2021;66:065027. [PMID: 33607648 DOI: 10.1088/1361-6560/abe836] [Reference Citation Analysis]
20 Yoon SM, Luterstein E, Chu FI, Cao M, Lamb J, Agazaryan N, Low D, Raldow A, Steinberg ML, Lee P. Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis. Cancer Med 2021. [PMID: 34288538 DOI: 10.1002/cam4.4139] [Reference Citation Analysis]
21 Bird D, Speight R, Al-Qaisieh B, Henry AM. Magnetic Resonance Imaging Simulation for Anal and Rectal Cancer - Optimising the Patient Experience. Clin Oncol (R Coll Radiol) 2021;33:e422-4. [PMID: 33992498 DOI: 10.1016/j.clon.2021.04.014] [Reference Citation Analysis]
22 Wilson C, Moseshvili E, Tacey M, Quin I, Lawrentschuk N, Bolton D, Joon DL, Chao M, Dunshea T, Kron T, Foroudi F. Assessment of Intrafraction Motion of the Urinary Bladder Using Magnetic Resonance Imaging (cineMRI). Clin Oncol (R Coll Radiol) 2020;32:101-9. [PMID: 31607612 DOI: 10.1016/j.clon.2019.09.056] [Reference Citation Analysis]
23 Huddart RA. Bladder Radiotherapy: Is Cinderella Ready for the Ball? Clin Oncol (R Coll Radiol) 2021;33:343-5. [PMID: 33895059 DOI: 10.1016/j.clon.2021.04.001] [Reference Citation Analysis]
24 Dohm A, Sanchez J, Stotsky-Himelfarb E, Willingham FF, Hoffe S. Strategies to Minimize Late Effects From Pelvic Radiotherapy. Am Soc Clin Oncol Educ Book 2021;41:158-68. [PMID: 34010045 DOI: 10.1200/EDBK_320999] [Reference Citation Analysis]
25 Chin S, Eccles CL, Mcwilliam A, Chuter R, Walker E, Whitehurst P, Berresford J, Van Herk M, Hoskin PJ, Choudhury A. Magnetic resonance‐guided radiation therapy: A review. J Med Imaging Radiat Oncol 2020;64:163-77. [DOI: 10.1111/1754-9485.12968] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 11.7] [Reference Citation Analysis]
26 Yuan J, Wong OL, Zhou Y, Chueng KY, Yu SK. A fast volumetric 4D-MRI with sub-second frame rate for abdominal motion monitoring and characterization in MRI-guided radiotherapy. Quant Imaging Med Surg 2019;9:1303-14. [PMID: 31448215 DOI: 10.21037/qims.2019.06.23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Wahlstedt I, Andratschke N, Behrens CP, Ehrbar S, Gabryś HS, Schüler HG, Guckenberger M, Smith AG, Tanadini-lang S, Tascón-vidarte JD, Vogelius IR, van Timmeren JE. Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.03.013] [Reference Citation Analysis]
28 Padgett KR, Simpson G, Asher D, Portelance L, Bossart E, Dogan N. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers. Physica Medica 2020;77:54-63. [DOI: 10.1016/j.ejmp.2020.07.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Symon N, Mattout J, Lewin R, Hammer L, Laufer M, Berger R, Leibowitz R, Dotan Z, Ben-Ayun M, Tsvang L, Weiss I, Symon Z. Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?: A Retrospective Single Institution Review. Am J Clin Oncol 2021;44:369-73. [PMID: 33927135 DOI: 10.1097/COC.0000000000000824] [Reference Citation Analysis]
30 Kron T, Fox C, Ebert MA, Thwaites D. Quality management in radiotherapy treatment delivery. J Med Imaging Radiat Oncol 2022;66:279-90. [PMID: 35243785 DOI: 10.1111/1754-9485.13348] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Stark LS, Andratschke N, Baumgartl M, Bogowicz M, Chamberlain M, Dal Bello R, Ehrbar S, Girbau Garcia Z, Guckenberger M, Krayenbühl J, Pouymayou B, Rudolf T, Vuong D, Wilke L, Zamburlini M, Tanadini-Lang S. Dosimetric and geometric end-to-end accuracy of a magnetic resonance guided linear accelerator. Phys Imaging Radiat Oncol 2020;16:109-12. [PMID: 33458353 DOI: 10.1016/j.phro.2020.09.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Richter A, Exner F, Weick S, Lawrenz I, Polat B, Flentje M, Mantel F. Evaluation of intrafraction prostate motion tracking using the Clarity Autoscan system for safety margin validation. Zeitschrift für Medizinische Physik 2020;30:135-41. [DOI: 10.1016/j.zemedi.2019.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Intven M, de Mol van Otterloo S, Mook S, Doornaert P, de Groot-van Breugel E, Sikkes G, Willemsen-bosman M, van Zijp H, Tijssen R. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience. Radiotherapy and Oncology 2021;154:172-8. [DOI: 10.1016/j.radonc.2020.09.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
34 Poon DMC, Yang B, Geng H, Wong OL, Chiu ST, Cheung KY, Yu SK, Chiu G, Yuan J. Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer. J Cancer Res Clin Oncol 2022. [PMID: 35199189 DOI: 10.1007/s00432-022-03950-1] [Reference Citation Analysis]
35 Paganetti H, Beltran C, Both S, Dong L, Flanz J, Furutani K, Grassberger C, Grosshans DR, Knopf A, Langendijk JA, Nystrom H, Parodi K, Raaymakers BW, Richter C, Sawakuchi GO, Schippers M, Shaitelman SF, Teo BKK, Unkelbach J, Wohlfahrt P, Lomax T. Roadmap: proton therapy physics and biology. Phys Med Biol 2021;66:05RM01. [DOI: 10.1088/1361-6560/abcd16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
36 Khalifa J, Supiot S, Pignot G, Hennequin C, Blanchard P, Pasquier D, Magné N, de Crevoisier R, Graff-Cailleaud P, Riou O, Cabaillé M, Azria D, Latorzeff I, Créhange G, Chapet O, Rouprêt M, Belhomme S, Mejean A, Culine S, Sargos P. Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder. Radiother Oncol 2021;161:95-114. [PMID: 34118357 DOI: 10.1016/j.radonc.2021.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Shelley CE, Barraclough LH, Nelder CL, Otter SJ, Stewart AJ. Adaptive Radiotherapy in the Management of Cervical Cancer: Review of Strategies and Clinical Implementation. Clin Oncol (R Coll Radiol) 2021;33:579-90. [PMID: 34247890 DOI: 10.1016/j.clon.2021.06.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Breto AL, Spieler B, Zavala-Romero O, Alhusseini M, Patel NV, Asher DA, Xu IR, Baikovitz JB, Mellon EA, Ford JC, Stoyanova R, Portelance L. Deep Learning for Per-Fraction Automatic Segmentation of Gross Tumor Volume (GTV) and Organs at Risk (OARs) in Adaptive Radiotherapy of Cervical Cancer. Front Oncol 2022;12:854349. [PMID: 35664789 DOI: 10.3389/fonc.2022.854349] [Reference Citation Analysis]
39 Corradini S, Alongi F, Andratschke N, Belka C, Boldrini L, Cellini F, Debus J, Guckenberger M, Hörner-Rieber J, Lagerwaard FJ, Mazzola R, Palacios MA, Philippens MEP, Raaijmakers CPJ, Terhaard CHJ, Valentini V, Niyazi M. MR-guidance in clinical reality: current treatment challenges and future perspectives. Radiat Oncol 2019;14:92. [PMID: 31167658 DOI: 10.1186/s13014-019-1308-y] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 36.7] [Reference Citation Analysis]
40 Barber J, Yuen J, Jameson M, Schmidt L, Sykes J, Gray A, Hardcastle N, Choong C, Poder J, Walker A, Yeo A, Archibald-Heeren B, Harrison K, Haworth A, Thwaites D. Deforming to Best Practice: Key considerations for deformable image registration in radiotherapy. J Med Radiat Sci 2020;67:318-32. [PMID: 32741090 DOI: 10.1002/jmrs.417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Mahmood F, Hjorth Johannesen H, Geertsen P, Hansen RH. Diffusion MRI outlined viable tumour volume beats GTV in intra-treatment stratification of outcome. Radiother Oncol 2020;144:121-6. [PMID: 31805516 DOI: 10.1016/j.radonc.2019.11.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
42 Gough J, Hall W, Good J, Nash A, Aitken K. Technical Radiotherapy Advances – The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation. Clinical Oncology 2022. [DOI: 10.1016/j.clon.2022.02.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Boekhoff M, Defize I, Borggreve A, Takahashi N, van Lier A, Ruurda J, van Hillegersberg R, Lagendijk J, Mook S, Meijer G. 3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy. Radiotherapy and Oncology 2020;147:1-7. [DOI: 10.1016/j.radonc.2020.03.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
44 Yuan J, Xue C, Lo G, Wong OL, Zhou Y, Yu SK, Cheung KY. Quantitative assessment of acquisition imaging parameters on MRI radiomics features: a prospective anthropomorphic phantom study using a 3D-T2W-TSE sequence for MR-guided-radiotherapy. Quant Imaging Med Surg 2021;11:1870-87. [PMID: 33936971 DOI: 10.21037/qims-20-865] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Klüter S, Katayama S, Spindeldreier CK, Koerber SA, Major G, Alber M, Akbaba S, Debus J, Hörner-Rieber J. First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany. Strahlenther Onkol 2020;196:691-8. [PMID: 32002567 DOI: 10.1007/s00066-020-01578-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
46 Hijab A, Tocco B, Hanson I, Meijer H, Nyborg CJ, Bertelsen AS, Smeenk RJ, Smith G, Michalski J, Baumann BC, Hafeez S. MR-Guided Adaptive Radiotherapy for Bladder Cancer. Front Oncol 2021;11:637591. [PMID: 33718230 DOI: 10.3389/fonc.2021.637591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
47 Nierer L, Eze C, da Silva Mendes V, Braun J, Thum P, von Bestenbostel R, Kurz C, Landry G, Reiner M, Niyazi M, Belka C, Corradini S. Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate. Radiat Oncol 2022;17. [DOI: 10.1186/s13014-022-02021-6] [Reference Citation Analysis]
48 Hunt A, Hanson I, Dunlop A, Barnes H, Bower L, Chick J, Cruickshank C, Hall E, Herbert T, Lawes R, McQuaid D, McNair H, Mitchell A, Mohajer J, Morgan T, Oelfke U, Smith G, Nill S, Huddart R, Hafeez S. Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer. Clin Transl Radiat Oncol 2020;25:46-51. [PMID: 33015380 DOI: 10.1016/j.ctro.2020.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
49 Kiser KJ, Barman A, Stieb S, Fuller CD, Giancardo L. Novel Autosegmentation Spatial Similarity Metrics Capture the Time Required to Correct Segmentations Better Than Traditional Metrics in a Thoracic Cavity Segmentation Workflow. J Digit Imaging 2021;34:541-53. [PMID: 34027588 DOI: 10.1007/s10278-021-00460-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Boekhoff M, Bouwmans R, Doornaert P, Intven M, Lagendijk J, van Lier A, Rasing M, van de Ven S, Meijer G, Mook S. Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: an R-IDEAL stage 1b/2a evaluation of technical innovation. Clinical and Translational Radiation Oncology 2022. [DOI: 10.1016/j.ctro.2022.03.008] [Reference Citation Analysis]